Works matching IS 09024441 AND DT 2025 AND VI 115 AND IP 1


Results: 12
    1

    Rilzabrutinib for the Treatment of Immune Thrombocytopenia.

    Published in:
    European Journal of Haematology, 2025, v. 115, n. 1, p. 4, doi. 10.1111/ejh.14425
    By:
    • Labanca, Caterina;
    • Martino, Enrica Antonia;
    • Vigna, Ernesto;
    • Bruzzese, Antonella;
    • Mendicino, Francesco;
    • Caridà, Giulio;
    • Lucia, Eugenio;
    • Olivito, Virginia;
    • Manicardi, Veronica;
    • Amodio, Nicola;
    • Neri, Antonino;
    • Morabito, Fortunato;
    • Gentile, Massimo
    Publication type:
    Article
    3
    4

    Dual Targeting of Pim and PI3 Kinases in Mature T‐Cell Lymphoma.

    Published in:
    European Journal of Haematology, 2025, v. 115, n. 1, p. 82, doi. 10.1111/ejh.14420
    By:
    • Lohrberg, M.;
    • Heber, M.;
    • Ries, L.;
    • Markus, K.;
    • Ksionsko, N.;
    • Schmidt, N.;
    • Nothnick, G.;
    • Thielking, L.;
    • O'Neill, M.;
    • Martínéz‐González, S.;
    • Blanco‐Aparicio, C.;
    • Pastor, J.;
    • Cunningham, D.;
    • Koch, R.
    Publication type:
    Article
    5
    6
    7

    Allogeneic Haematopoietic Stem Cell Transplantation Using Reduced‐Intensity Fludarabine, Busulfan and Anti‐T‐Lymphocyte Globulin With Strategic Donor Lymphocyte Infusion in Older Patients With Myeloid Malignancy.

    Published in:
    European Journal of Haematology, 2025, v. 115, n. 1, p. 36, doi. 10.1111/ejh.14417
    By:
    • Armstrong, Chris;
    • Conneally, Eibhlin;
    • Flynn, Catherine;
    • Browne, Paul;
    • Chonghaile, Mairead Ni;
    • Galligan, Carmel Ann;
    • Foy‐Stones, Hayley;
    • Gardiner, Nicola;
    • Lee, Greg;
    • Orfali, Nina
    Publication type:
    Article
    8

    Central Nervous System Manifestations of Graft‐Versus‐Host Disease.

    Published in:
    2025
    By:
    • Desai, Nihar;
    • Khaire, Niranjan;
    • Cyriac, Sunu;
    • Alrumeh, Aseem Saleh;
    • Diamandis, Phedias;
    • Mandell, Daniel M.;
    • Moya, Tommy Alfaro;
    • Al‐Shaibani, Eshrak;
    • Novitzky‐Basso, Igor;
    • Pasic, Ivan;
    • Law, Arjun Datt;
    • Michelis, Fotios V.;
    • Kumar, Rajat;
    • Kim, Dennis Dong Hwan;
    • Mattsson, Jonas;
    • Viswabandya, Auro
    Publication type:
    Case Study
    9
    10

    Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients.

    Published in:
    European Journal of Haematology, 2025, v. 115, n. 1, p. 16, doi. 10.1111/ejh.14413
    By:
    • Morabito, Fortunato;
    • Martino, Enrica Antonia;
    • Galli, Monica;
    • Offidani, Massimo;
    • Zambello, Renato;
    • Bringhen, Sara;
    • Giuliani, Nicola;
    • Califano, Catello;
    • Brunori, Marino;
    • Gagliardi, Alfredo;
    • Sgherza, Nicola;
    • Quinto, Angela Maria;
    • Barilà, Gregorio;
    • Belotti, Angelo;
    • Cerchione, Claudio;
    • Casaluci, Gloria Margiotta;
    • Fontana, Raffaele;
    • Bongarzoni, Velia;
    • Tarantini, Giuseppe;
    • Derudas, Daniele
    Publication type:
    Article
    11

    Home‐Based Daratumumab in Patients With Multiple Myeloma.

    Published in:
    European Journal of Haematology, 2025, v. 115, n. 1, p. 72, doi. 10.1111/ejh.14409
    By:
    • Rosenberg, Tine;
    • Kirkegaard, Jannie;
    • Gundesen, Michael Tveden;
    • Rasmussen, Maja Kjær;
    • Dieperink, Karin Brochstedt;
    • Lund, Thomas
    Publication type:
    Article
    12

    Issue Information.

    Published in:
    European Journal of Haematology, 2025, v. 115, n. 1, p. 1, doi. 10.1111/ejh.14231
    Publication type:
    Article